Assessment of primary care practitioners’ attitudes and interest in pharmacogenomic testing
Identify the attitudes and interests of primary care providers (PCPs) in applying clinical pharmacogenomics (PGx) test results. A questionnaire was designed and then disseminated to PCPs across the MedStar Health System. Ninety of 312 (29%) PCPs responded and were included in analyses. Seventy-six (...
Gespeichert in:
Veröffentlicht in: | Pharmacogenomics 2020-10, Vol.21 (15), p.1085-1094 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Identify the attitudes and interests of primary care providers (PCPs) in applying clinical pharmacogenomics (PGx) test results.
A questionnaire was designed and then disseminated to PCPs across the MedStar Health System.
Ninety of 312 (29%) PCPs responded and were included in analyses. Seventy-six (84%) had heard of PGx and 12 (13%) previously ordered PGx testing. Most, 68 (76%), believed PGx can improve care; however, a minority, 23 (26%), reported confidence in using PGx in prescribing decisions. Sixty-four (70%) wanted a pharmacist consultation. PCPs desired PGx for antidepressants (75%), proton pump inhibitors (72%) and other medications.
Most PCPs felt unprepared to interpret PGx results and desired pharmacist consultations. These data can inform future PGx implementations with PCPs. |
---|---|
ISSN: | 1462-2416 1744-8042 |
DOI: | 10.2217/pgs-2020-0064 |